Objective: Family planning discussions are an important aspect of medical care for women with systemic lupus erythematosus (SLE) as active disease is a risk factor for poor pregnancy outcomes, and the medications used for treatment can be harmful to the fetus when used during conception and pregnancy. Our objective was to examine the impact of patient perception of quality and type of communication on receiving contraception counseling. Methods: Data were derived from patients enrolled in the University of California, San Francisco Lupus Outcomes Study. Individuals participate in a yearly structured telephone interview that includes assessment of contraception counseling when starting new medications, and measures of communication and decision making. Logistic regression was performed to identify predictors of not receiving contraception counseling. Results: Of the 68 women included in this analysis, one-third did not receive contraception counseling when starting new medications. Older age, white race, depressive symptoms, and higher SLE disease activity were independently associated with not receiving contraception counseling. Participants who did not receive contraception counseling rated their physicians lower in shared decision-making (SDM) communication. Conclusions: This study demonstrates a gap in family planning counseling among women with SLE starting new medications. Future studies to address these potential areas of intervention, including education about the need for contraception through menopause, and mechanisms to engage in SDM surrounding contraception are needed to improve quality of care for women with lupus. Lupus (2016) 25, 12-17.
Background
Systemic lupus erythematous (SLE) often affects women in their reproductive years, making family planning and pregnancy discussions an important aspect of medical care. 1 Many of the immunosuppressive medications used to treat the manifestations of SLE have demonstrated or theoretical harm to the fetus. Prior to starting these medications, patients should be counseled about these risks, and a plan for contraception should be made and documented. 1 Despite general consensus, there are known gaps in implementing this standard in clinical practice. 2 An analysis of a large health maintenance organization demonstrated that women who filled prescriptions for medications with demonstrated human fetal risk were no more likely to have received contraception counseling, or to have filled a contraception prescription than those using lower-risk medications. 3 Conversely, some medications widely regarded as low risk for causing fetal harm are discontinued during pre-conception or pregnancy, likely because of unawareness that the risk of exacerbating their disease may outweigh the risks of using the medication during pregnancy. 4 Women with SLE face a higher risk of pregnancy complications including preterm delivery, preeclampsia, and pregnancy loss. This risk can be mitigated by timing pregnancy for periods of lower disease activity, a process that relies on a clear understanding of a woman's pregnancy intention and timely and appropriate counseling. 5, 6 Despite these risks, many women with lupus remain unprotected from the possibility of unintended pregnancy. One clinic-based study found that more than half of sexually active patients with SLE failed to use a highly effective form of contraception. 7 Opportunities for counseling are often missed. A survey of physicians treating women with systemic inflammatory diseases found that only 32%-56% of physicians reported having talked about family planning and pregnancy with their female patients of reproductive age. 8 Most patients reported that their family planning and pregnancy concerns were not adequately addressed or settled during their appointments. 8 When discussion does occur, patients often report inconsistency in the advice they receive from different providers. 8, 9 In this study, we investigated rates and predictors of not receiving contraception counseling in women with lupus starting new medications with known or potential risks to the fetus when used during pregnancy. Sociodemographic factors were investigated as predictors of not receiving contraception counseling due to the well-described disparities in health associated with race, income and class in the United States (US). 10 Patients report significantly lower rates of family planning counseling discussions during clinical encounters than clinicians; 8 therefore, of interest was whether patient perception of the quality and type of communication with their physician could predict receiving contraception counseling. We hypothesize that patients who rate their physicians lower in communication are less likely to report contraception counseling when starting new potentially teratogenic medications.
Methods

Data source
Data derived from the University of California Lupus Outcomes Study (LOS), a prospective observational study of individuals with lupus, previously described in detail. 11 Briefly, LOS participants were recruited from an existing cohort of individuals with physician-diagnosed lupus, confirmed by chart review. Enrollment began in 2003, and continued through 2010, with 80% of individuals enrolled prior to 2006. Individuals participate in an annual structured telephone interview conducted by experienced survey workers that averages 50 minutes in length. The interview includes validated measures of SLE disease activity and manifestations, general physical and mental health status, medications, health care utilization, health insurance coverage and sociodemographic characteristics. Recruitment for the LOS occurred in several different settings in an effort to capture the full spectrum of SLE, including academic and community practices (33%), lupus support groups and conferences (26%), and newsletters, websites and other forms of publicity (41%). Over the course of the study, there have been 1349 individuals in the LOS and 8358 person-years of observation (6.2 years per person). Year-to-year re-interview rates have averaged 93% including deaths, or 95% excluding them.
Variables Primary outcome: assessing contraception counseling
Each year, patients are asked whether they have started new medications for their lupus using a pre-selected list of medications commonly used to treat the manifestations of SLE. For the past five years, participants were asked the question ''At that time, were you also given information about birth control, contraception, or not getting pregnant?'' when they endorsed starting azathioprine, mycophenolate, methotrexate, cyclosporine, leflunomide, cyclophosphamide, rituximab, abatacept, or belimumab.
Measures of assessing communication between patients and providers
Beginning in 2012, we included components of the Consumer Assessment of Healthcare Providers and Systems (CAHPS) 12 and the Interpersonal Processes of Care (IPC) assessment 13 to evaluate how participants viewed interaction with their physicians. The Agency for Healthcare Research and Quality designed CAHPS items to evaluate interactions between patients and health care systems in domains such as provider communication, promptness, timeliness of care, and care coordination as a large-scale assessment of the health plans. The IPC scale was developed to assess how quality of interpersonal process of care might affect technical process and outcomes, incorporating issues that are important to minority and low socioeconomic populations using a validated self-report instrument. Communication with their provider was assessed using 15 items, shared decision making (SDM) assessed by six items, and trust
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was assessed using six items. Items were coded differently in the CAHPS assessment and the IPC assessment, and were therefore transformed to a 0 to 100 scale for uniformity using a strategy discussed by Morales and colleagues, 14 and in another publication using the LOS. 15 Only patients who had seen the primary provider who treats their lupus within the past year were asked these questions. The online Appendix 1 includes a complete listing of items from CAHPS and IPC included for this analysis to assess communication.
Education and income
Education level was assessed each year as less than high school, high school graduate, some college, associate/trade degree, bachelor's degree, and post-bachelor's degree. This was later dichotomized into high school education or less, and above high school education. Household income was also assessed each year, and for this analysis dichotomized into less than 125% of the federal poverty line, or at or above 125% of the federal poverty line.
Health literacy
Health literacy was measured using a single item literacy screener, a self-report question created by Morris and colleagues. 16 The question ''How often do you have someone like a family member, friend, hospital or clinic worker or caregiver help you read health plan materials, such as written information about your health or care you are offered?'' Possible answers were never, sometimes, usually, or always. Patients answering ''sometimes,'' ''usually,'' or ''always'' were considered as demonstrating limited health literacy.
Disease status SLE disease status was evaluated using two measures, the Systemic Lupus Activity Questionnaire (SLAQ) and the Brief Index of Lupus Damage (BILD). The SLAQ, a 24-question inventory of self-reported signs and symptoms, is a validated measure of SLE disease activity over the preceding three months, used with research when a clinical examination is not possible. 17 It is scored on a scale of 0 to 47. The BILD is a patient-reported, 41-item assessment designed to evaluate cumulative lupus damage involving 12 organ systems. 18 It has been previously validated, and found to have good agreement with the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI), a measure requiring the assessment of a clinician. 19 
Depressive symptoms
The Center for Epidemiologic studies Depression Scale (CESD) is a commonly used 20-item assessment of depression symptoms that is patient reported. 20 Scores range from 0 to 60 with higher scores reflecting increased severity of depression. It has been previously used with SLE, with cut points of 24 consistent with major depression, and 20 and above consistent with any depressive mood disorder. 21 
Statistical analysis
This analysis includes women who started new medications with known or theoretical harm to the fetus when used during pregnancy who were less than 45 years old at that time, and who had not had prior hysterectomy or premature ovarian failure. We report patient provider communication, provider trust, SDM, and clinical and sociodemographic characteristics for these participants.
Using univariate logistic regression models, we examined predictors of the outcome of receiving contraception counseling. Predictors examined include age, race/ethnicity (white, African American, Asian, Latina, other), education (high school education or less, more than a high school education), depression as measured by CES-D, disease activity using SLAQ scores, cumulative damage using BILD scores, and communication variables including patient provider communication, provider trust, and SDM. Finally, we constructed multivariate logistic regression models using significant predictors from the biavariate analysis to examine independent predictors of receipt of contraceptive counseling. Sensitivity analyses excluding women who started azathioprine were performed.
All data were analyzed using Stata, version 13 (Stata-Corp). The University of California, San Francisco Committee on Human Research approved the research protocol. All participants gave their informed consent to be part of the study.
Results
A total of 68 women were included in this analysis between the ages of 20 and 45. Table 1 shows selected demographic characteristics for participants.
One-third of women did not report receiving contraception counseling when starting new medications with known or theoretical harm to the fetus when used during pregnancy. In univariate
analyses, women who were older, white, had higher levels of depressive symptoms and had high disease activity were less likely to receive contraception counseling ( Table 2) . Patients who rated their providers low on the SDM scale were also less likely to receive counseling. Health literacy was not associated with receiving counseling. In multivariate analyses, these factors did not retain statistical significance. Sensitivity analyses, excluding women who started azathioprine, demonstrated no major differences.
Discussion
This analysis demonstrates a continued gap in adequate patient-clinician communication and discussions around teratogenic medications, family planning and pregnancy issues in women with lupus. Our study demonstrates that one-third of participants did not receive adequate counseling. We found multiple significant predictors in bivariate analyses, but none of these remained significant in the multivariate model, perhaps because the small sample size did not provide enough statistical power. A sample size of at least 200 participants would be needed to achieve statistical significance. In our study, women who were older were less likely to receive contraception counseling. Though fertility declines after age 40, pregnancy is still common. 22 The US Department of Health and Human Services has reported a 2% increase per year in the birth rate for women age 40-44 since 2000, and a 7% increase in births in women age 45-49 in 2013. 23 It is estimated that almost half of pregnancies in women who are older than 40 are unplanned. 23 It is recommended that women use contraception until cessation of menses for two years if younger than 50 and one year if older than age 50. 24 White women were less likely to report contraception counseling than women of other races. Historically, the influence of eugenics has significantly affected public policy surrounding reproductive health and has disproportionately affected women of color, resulting in tragedies such as the forced and coerced sterilization of women. 25 Though public policy has shifted, the degree to which remnants of such attitudes persist is difficult to assess. Borrero et al., using data from the National Survey of Family Growth, found that Hispanic and African American women were more likely than white women to report contraception counseling, though frequency of accessing family planning services was similar between groups. 26 They reflect on the role of clinician stereotypes in contraception counseling, noting that more counseling does not necessarily correspond to the quality of counseling provided. 26 The women in these analyses had a clear indication for receiving counseling. This makes it a difficult task to distinguish necessary contraception counseling from potential clinician bias toward increased contraception counseling of women of color, or to assume that white women do not need such counseling. It is also important to note that in this analysis, white women were older than non-white women, though no effect modification was detected.
Participants with higher CESD scores, indicating disorders on the depressive spectrum, were less likely to report contraception counseling. Depressive symptoms can be associated with impairment in cognitive functioning, particularly in the domain of executive function, affecting memory, attention, problem solving, and goal setting. It is possible that patients have been counseled regarding contraception, but because of their depressive symptoms did not recall it. 27 We identified higher disease activity as measured by the SLAQ score as a predictor of not receiving contraception counseling. This finding is important, as patients with higher disease activity who become pregnant are at higher risk for poor pregnancy outcomes. 5, 6 Additionally, patients with higher disease activity are often treated with medications that are potential teratogens in order to treat their lupus, and therefore have a great need for family planning and contraception counseling.
General clinician communication was rated highly among women who did and did not report receiving contraception counseling. Participants in both groups scored clinicians lower on SDM.
However, patients who did not receive contraception counseling scored their physicians significantly lower in this area. Data on health literacy, which can affect communication, were available for 56 participants, with no statistical differences between the groups. Trust in the physician can also affect SDM, but was rated highly in both groups. Dehlendorf et al. in their qualitative study of communication surrounding contraception also describe a paucity of SDM in their analysis of 50 tape-recorded clinician-patient encounters in primary care clinics. In a separate study, Dehlendorf et al. investigated women's opinions and values regarding interactions with family planning providers in semi-structured interviews, and found that most women desired provider participation in the decision-making process in a context that emphasizes patient values and preferences. 28 This could be an important area of needed innovation, as there has been limited success with contraception interventions to date. 29 Limitations of this study include the relatively small number of participants in the LOS who met the criteria for the analysis and the reliance on participant recall via structured telephone interviews, which may underestimate counseling. However, participant recall may be a more meaningful measure than actual objective measurement of counseling, as only women who recall receipt of contraception counseling would be able to act on the information. We did not have data on current method of contraception, which may affect the interpretation of this data. Women with longacting reversible contraception (LARC) may not receive as much dedicated contraception counseling, though prior studies in this cohort demonstrated low rates of LARC use. 2 Azathioprine, which is regarded clinically as acceptable for use during pregnancy for women with SLE with severe disease manifestations, was included in this analysis. Reported adverse outcomes in infants exposed to azathioprine in utero include thymic atrophy, leukopenia, anemia, thrombocytopenia, chromosome aberrations, decreased immunoglobulin levels and infection; however, no specific physical malformations have been associated with its use. Some women who intended pregnancy may have been advised to stop other immunosuppressant agents associated with worse infant outcomes and start azathioprine because of its relative safety. The question posed in our study would not capture these women. We performed sensitivity analyses, excluding women with azathioprine, and found no major differences in effects.
Our data suggest a gap in contraception counseling among women with lupus starting new potentially teratogenic medications who are older, who have depressive disorders, and who have higher disease activity. Though overall communication was rated highly, patients who rated their clinicians lower on SDM reported less contraception counseling. Future studies to address these potential areas of intervention, including education about the need for contraception through menopause, and mechanisms to engage in SDM surrounding contraception, are needed to improve the quality of care for women with lupus.
